Skip to content
Glioblastoma Radiation Therapy
Radiation Oncology

Glioblastoma Radiation Therapy

About This Department

 
Neuro-Oncology

Surgery cannot remove every glioblastoma cell. Radiation with temozolomide is the treatment that reaches the rest.

Someone you love, or you yourself, has had a brain operation or a biopsy. The pathology report says glioblastoma. The next treatment is already decided in outline, and it is radiotherapy to the area of the tumor with a daily chemotherapy capsule called temozolomide. That combination became the worldwide standard in 2005, when a trial of 573 patients showed that adding temozolomide to six weeks of radiation raised the share of patients alive at two years from 10.4 percent to 26.5 percent. Glioblastoma remains a serious diagnosis. Treatment does not cure it in most people. It does add time, often good time. How much depends on age, on how much tumor the surgeon removed, and on a marker called MGMT. What follows explains the course, the choices inside it, the timing after surgery, which matters more than families are told, and what a stay of several weeks in Istanbul involves for the patient and for whoever comes along.

26.5% vs 10.4%
Alive at two years, radiation with and without temozolomide, NEJM 2005
60 Gy in 30
Standard course, five days a week for six weeks
40 Gy in 15
Three-week course for patients of 65 and over, NEJM 2017
Free
Review of pathology and MRI
Free consultation
We review the file without charge and without obligation, and because timing matters we ask you to send it as soon as the operation is over. The pathology report with MGMT and IDH results, the MRI from before surgery and the one taken within three days after it, the operation note, and the current doses of steroid and anti-seizure medicine. A radiation oncologist and a neurosurgeon read them together, and a coordinator replies in your own language with the proposed schedule and the date treatment could start.

Why radiation follows surgery

Glioblastoma Radiation Therapy exists because of how this tumor grows. A glioblastoma has no edge. The bright mass on the MRI is its densest part, and around it tumor cells travel along nerve fibers into brain that looks normal on any scan, two centimeters and more from the visible margin.

A neurosurgeon can remove what is visible. Nobody can remove what is not, because those cells sit inside working brain.

Surgery takes the mass. Radiation treats the ground it grew in. The radiation field covers the cavity, any tumor left behind, and a margin of brain around them where the scattered cells are most likely to be.

That explains two things families ask about. Doctors recommend radiation even after a surgeon reports a complete removal, since complete refers to the scan and not to the cells. And focused single-session treatments such as Gamma Knife have no place in a newly diagnosed glioblastoma, because a beam sharp enough to spare everything outside the visible tumor spares the tumor cells out there too.


The trials behind the standard treatment

Four randomized trials define current practice, and each one answers a question a family will meet.

Scroll this table sideways if your screen is narrow.
The trials behind the treatment
Trial Who and what Result
Stupp and colleagues, New England Journal of Medicine 2005 573 adults, median age 56. Radiation of 60 Gy alone, or with daily temozolomide followed by six monthly cycles Median survival 14.6 months against 12.1. Alive at two years, 26.5 percent against 10.4 percent
Hegi and colleagues, same journal, same trial 206 tumors from that trial tested for MGMT methylation, found in 45 percent With methylated MGMT, 21.7 months with temozolomide against 15.3 without. Little benefit from the drug in unmethylated tumors
Perry and colleagues, New England Journal of Medicine 2017 562 patients aged 65 to 90. Three weeks of radiation, 40 Gy in 15 sessions, alone or with temozolomide 9.3 months against 7.6. With methylated MGMT, 13.5 against 7.7. Quality of life the same in both groups
Stupp and colleagues, JAMA 2017 695 patients who had finished chemoradiation. Maintenance temozolomide alone, or with tumor-treating fields worn on the scalp 18 hours a day 20.9 months against 16.0 from randomization. Skin irritation under the pads in 52 percent

Read the numbers for what they are. A median marks the point that half of patients pass, and some pass it by years. The figures come from trial patients, who are fitter than average, yet the direction has not changed in twenty years, with radiation and temozolomide as the backbone and everything newer added on top of it.


What the pathology report decides

Two laboratory results on the tumor shape the plan more than the scan does.

Scroll this table sideways if your screen is narrow.
Tumor markers and what they change
Marker What it means Effect on radiotherapy
MGMT promoter methylation The tumor has switched off a gene that repairs the DNA damage temozolomide causes. Found in a little under half of glioblastomas Temozolomide works much better. In an older or frail patient with an unmethylated tumor, radiation alone is a reasonable choice
IDH mutation Since the 2021 WHO classification, a tumor with this mutation is no longer called glioblastoma. It is an astrocytoma, grade 4 at most, and behaves more slowly Radiation and temozolomide are still used. Survival is counted in years more often than months, and late effects of radiation matter more

If your report lacks either result, ask the laboratory that holds the tissue to run it. Both run on the stored block. We arrange it in Istanbul on slides you bring.


Six weeks, three weeks or one

Doctors use three schedules, and choosing between them means judging the person as much as the tumor.

Scroll this table sideways if your screen is narrow.
Radiotherapy schedules for glioblastoma
Schedule For whom Temozolomide
60 Gy in 30 sessions over six weeks Adults up to 70 or so in good general condition Daily during radiation, then six monthly cycles
40 Gy in 15 sessions over three weeks Patients of 65 to 70 and over, and younger patients who are frail Daily during radiation and afterwards, above all when MGMT is methylated
25 Gy in 5 sessions over one week Very frail or very elderly patients for whom three weeks of daily travel is too much Usually none

Between 65 and 70

The two main trials overlap in this age band, and fitness decides. A 68-year-old who walked into the hospital, lives independently and had most of the tumor removed is offered six weeks. A 68-year-old who needs help to dress is better served by three, since the Perry trial showed, in a group whose median age was 73, that the shorter course with temozolomide extends life without lowering its quality.

Higher doses have been tried repeatedly. None has improved survival, and all have increased damage to normal brain.


The clock after surgery

Radiation should start three to six weeks after surgery. Earlier than that the wound has not healed. Much later, and a fast-growing tumor has had time to regrow. Planning MRI scans show exactly that in a share of patients who waited.

A workable timetable for a patient operated on at home
Day 1 to 3 after surgery, the early MRI, and your first message to us with the reports. Week 1 brings pathology with markers and our review. In week 2 your neurosurgeon clears you to fly and you travel. Week 3 holds the consultation, the mask, the planning CT and the MRI, and the first session follows in week 4. Surgery can also be done at Biruni Hospital, which removes the flight from the critical weeks altogether.

Flying after a craniotomy needs the surgeon's agreement. Air trapped inside the skull at operation expands at altitude, and neurosurgeons want it absorbed before a flight, which takes a few weeks and shows on a CT scan done shortly before the planned date of travel. Tell us the date of surgery and we plan around it.


How the target is drawn

Mask
A sheet of thermoplastic is warmed, molded over the face and left to set. It clips to the table and holds the head still to within a millimeter or two. Breathing is normal through it, and people who fear closed spaces manage with a mild sedative for the first sessions.
Imaging
A planning CT in the mask, and a fresh MRI with contrast. The early MRI after surgery is no longer enough by now, since the cavity changes shape within weeks.
Drawing the target
The 2023 guideline of the European radiotherapy and neuro-oncology societies, ESTRO and EANO, defines one target. It takes the surgical cavity and any remaining tumor that lights up on the MRI, and adds 15 millimeters in all directions, trimmed where bone or the membranes of the brain form a natural barrier.
Protecting what matters
The optic nerves and their crossing, the brainstem, the eyes, the inner ears and, where the tumor allows, the memory structures of the opposite side each receive a dose limit. Intensity modulated arcs shape the dose around them.
Daily checking
With image guidance on the treatment machine, the same guideline advises a setup margin of 3 millimeters or less.
 

Radiotherapy at Biruni Hospital is delivered on an Elekta Versa HD linear accelerator with cone-beam CT imaging before treatment. Planning takes five to seven working days from the mask.


Living through the weeks of treatment

Each session lasts fifteen minutes and cannot be felt. The treatment as a whole is felt, gradually, from the third week.

  • Temozolomide capsules are taken every day including weekends, on an empty stomach, an hour before radiation or at bedtime, with an anti-sickness tablet half an hour before.
  • Blood counts are checked every week, because the drug lowers platelets and white cells. In the 2005 trial this reached a serious level in 7 percent of patients.
  • An antibiotic to prevent a particular lung infection is prescribed for the weeks of combined treatment, since steroids and temozolomide together weaken that part of immunity.
  • Dexamethasone, the steroid that controls brain swelling, is kept at the lowest dose that controls symptoms and reduced when possible.
  • Anti-seizure medicine continues unchanged. Driving is off limits in nearly every country after a seizure or a craniotomy, for a period set by local law.

The radiation oncologist sees you every week. Say what has changed, however small. A new headache in the morning, more weakness on one side, or sleepiness that is out of proportion can mean swelling, and a change of steroid dose fixes it within a day or two.


Side effects, early and late

During treatment and the month after

Tiredness affects nearly everyone. It peaks in the last two weeks and the two weeks that follow. Hair falls out over the treated area from week three, in a patch that matches the beam paths, and regrows within three to six months for the majority, thinner where the dose was highest and sometimes with a different texture. The scalp reddens and itches. Nausea comes from the capsule more than from the radiation. A few weeks after the course ends, some people go through a spell of heavy sleepiness and low mood that lasts two weeks and lifts by itself.

Months to years later

Slower thinking, poorer short-term memory and difficulty doing two things at once affect a share of longer-term survivors. The tumor, the surgery, the seizure medicines and the radiation all contribute. Nobody can divide the blame. Radiation necrosis, an area of treated brain that breaks down and swells, appears in a small minority from six months onwards. Steroids treat it, sometimes with the drug bevacizumab added, and occasionally surgery is needed. Hormone deficiency follows in some patients when the pituitary region lies in the field. A yearly blood test finds it.

Honesty requires one more sentence. For most patients with glioblastoma the late effects of radiation are a problem they would be glad to live long enough to have.


The first scan afterwards, and the months that follow

The first MRI can mislead

The first scan is done four weeks after the last session. In a fifth to a third of patients it looks worse. More contrast uptake, more swelling. In many of them the cause is the treatment working, a reaction called pseudoprogression, which is commoner in MGMT-methylated tumors and settles over the following months. For that reason neuro-oncologists avoid declaring failure on any scan within twelve weeks of radiation unless new tumor appears outside the treated area, and they continue temozolomide while watching, repeating the MRI after a further four to eight weeks.

Six cycles of temozolomide

After a four-week break the drug restarts at a higher dose. Five days in every twenty-eight. Six cycles. A capsule, nothing more. Any oncologist at home can prescribe and monitor it with a blood count before each cycle and an MRI every two to three months, and that is how nearly all our international patients continue.

Tumor-treating fields

Marketed as Optune, this is a set of adhesive pads worn on a shaved scalp and connected to a battery pack, delivering a weak alternating electric field that disturbs dividing cells. In the 2017 trial it added nearly five months to median survival, 20.9 against 16.0, when worn 18 hours a day alongside maintenance temozolomide, at the price of skin irritation under the pads in half of users. Availability and reimbursement differ greatly between countries, and the device is supplied by its manufacturer, so the practical question is whether it can be obtained where you live.


If the tumor comes back

Most glioblastomas return. Most return within two centimeters of where they started, inside the area already irradiated. Reading that sentence is hard, and families planning ahead need it.

No single standard exists for recurrence, and the choice depends on how long the first treatment held, on where the new growth sits and on how the patient is. Operating again helps when the tumor is reachable and causing pressure, and it also provides fresh tissue for the pathologist. Restarting temozolomide makes sense if it worked the first time and was stopped more than a few months ago. Lomustine and bevacizumab are the usual second-line drugs. A second, shorter course of radiation to a small volume, 35 Gy in 10 sessions being a common schedule, is an option when at least six months have passed since the first and the new growth is small enough to treat without overlapping the optic nerves or the brainstem. Clinical trials deserve a serious look at this stage, at home or abroad. And for some patients the right decision is to stop treating the tumor and treat the symptoms well.

Everything on one site
Neurosurgery, radiotherapy and chemotherapy are delivered at Biruni Hospital on the same site, so the team that reads a worrying scan can offer any of these without sending the patient elsewhere. Patients who are followed at home can send each MRI for a second reading at no charge.

How long to stay in Istanbul, and flying

Scroll this table sideways if your screen is narrow.
Time in Istanbul by schedule
Schedule Planning Treatment Total
60 Gy in 30 sessions 1 to 1.5 weeks 6 weeks 7 to 8 weeks
40 Gy in 15 sessions 1 to 1.5 weeks 3 weeks 4 to 5 weeks
25 Gy in 5 sessions 1 week 1 week 2 weeks
Surgery at Biruni Hospital, then the six-week course 3 to 4 weeks of recovery, pathology and planning 6 weeks 10 to 11 weeks

You attend as an outpatient, five days a week. Weekends stay free.

Radiation sets no limit on flying, and you are not radioactive. Brain swelling causes the real concern. Anyone whose symptoms are controlled on a stable steroid dose can fly home in the days after the last session, with the steroid and anti-seizure tablets in hand luggage, a letter describing the diagnosis and treatment, and a companion in the next seat. Break up a long flight. If the last week brought new headaches or drowsiness, we settle that first.


What the quote is made of

No price appears here, because a glioblastoma quote is a sum of parts that differ from one patient to the next, and the parts are these. The schedule decides the largest share, thirty sessions costing more than fifteen. Hospitals charge planning once, and it covers the mask, the planning CT, the MRI and the physics work. Pharmacies price temozolomide by body surface area and by the number of days, and whether the quote includes the capsules or expects you to buy them matters a great deal. Weekly blood tests, supporting medicines and consultations are small lines. Over six weeks they add up. An admission for swelling or a seizure is never inside a package. Published packages from Turkish hospitals and medical travel agencies for brain radiotherapy cover consultation, planning, all sessions and transfers, and leave out drugs, MRI scans during follow-up, flights, and seven weeks of accommodation for two people, which is a large sum in its own right.

A quote for surgery is separate and depends on the position of the tumor, the use of navigation, monitoring or awake mapping, and the days in intensive care, so send the file first, and the figure you receive will name the schedule it assumes and say whether temozolomide is included.


For the person traveling with the patient

A patient with glioblastoma should not travel or stay alone. The companion carries more here than in almost any other treatment. You will manage the tablets, notice the changes the patient does not, and be the memory for every conversation with the doctors.

Biruni Hospital assigns one coordinator from the first message, and the international patients team works in English, Arabic, French, Russian, Serbian, Romanian and Spanish, with interpreters arranged for other languages, which matters most when a tired patient with word-finding difficulty is trying to follow a consultation. The office arranges accommodation for both of you for the whole course, close enough that the daily trip stays short, along with airport transfers and the daily car. It issues the appointment confirmation and invitation letter for a visa, naming the hospital and the treating doctor, ten days or so before travel. After any admission, the room has a bed for you. The kitchen provides halal, vegetarian and diabetic meals, the last of these being relevant because steroids raise blood sugar. A prayer room is on site. Request a female physician in your first message if you want one. Bring a month of the patient's regular medicines from home, in their boxes, so that doses can be checked against what we prescribe.

Look after yourself as well. Seven weeks wears anyone down. Another family member who takes over for two weeks in the middle makes a difference.


Care at home

Once you get back home, three people need the handover file. The oncologist who will prescribe temozolomide, the neurologist or family doctor who manages seizures and steroids, and whoever reads the MRI scans. The file contains the radiation summary with dose, sessions and the doses to the optic nerves and brainstem, the planning images, the pathology with markers, the schedule for the six cycles, and the name and direct contact of the doctor who treated you here.

  • MRI four weeks after radiation, then every two to three months
  • Blood count before each temozolomide cycle, and on day 21 of the cycle
  • Steroid dose reviewed at every visit, with the aim of stopping
  • A plan, written down, for what to do if a seizure lasts more than five minutes

Your coordinator stays on the same WhatsApp number. Send each new MRI, and the radiation oncologist will compare it with the treatment plan, which is the only reliable way to tell regrowth from radiation effect when the change lies inside the treated area.


Glioblastoma Radiation Therapy FAQ

How long does radiation therapy for glioblastoma take?
Six weeks for the standard course of 30 sessions, three weeks for the 15-session course used from the age of 65 to 70, and one week for the shortest course. Each session lasts fifteen minutes, Monday to Friday. Add seven to ten days at the start for the mask, the scans and the planning.
Does radiation cure glioblastoma?
In most patients, no. It extends life and delays the return of the tumor. In the trial that set the standard, median survival was 14.6 months with radiation and temozolomide, and 26.5 percent of patients were alive at two years. Patients with a methylated MGMT marker did considerably better.
Is Gamma Knife or CyberKnife better than ordinary radiotherapy for glioblastoma?
No. Glioblastoma spreads into brain that looks normal on the scan, so the field has to include a margin of 15 millimeters around the cavity. Radiosurgery machines are built to avoid exactly that margin. Biruni Hospital treats glioblastoma on an Elekta Versa HD linear accelerator and does not operate a Gamma Knife or CyberKnife.
How soon after surgery should radiation start?
Three to six weeks. Patients operated on elsewhere should send their reports in the first days after surgery so that travel, the mask and planning fit inside that window.
Can we fly home straight after the last session?
Yes, provided symptoms are stable on a steady steroid dose. Carry the medicines in hand luggage, travel with a companion, and bring the letter we provide describing the treatment.
Will the staff be able to talk to us in our language?
The international patients team works in English, Arabic, French, Russian, Serbian, Romanian and Spanish and arranges interpreters for other languages, including for the weekly review during treatment.
Who continues the treatment when we are home?
An oncologist near you prescribes the six cycles of temozolomide capsules and orders the MRI scans. We send a full handover file, and our radiation oncologist will compare any later MRI with the original plan at no charge.

References

  1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. The New England Journal of Medicine. 2005;352(10):987-996.
  2. Hegi ME, Diserens AC, Gorlia T, et al. MGMT gene silencing and benefit from temozolomide in glioblastoma. The New England Journal of Medicine. 2005;352(10):997-1003.
  3. Perry JR, Laperriere N, O'Callaghan CJ, et al. Short-Course Radiation plus Temozolomide in Elderly Patients with Glioblastoma. The New England Journal of Medicine. 2017;376(11):1027-1037.
  4. Niyazi M, Andratschke N, Bendszus M, et al. ESTRO-EANO guideline on target delineation and radiotherapy details for glioblastoma. Radiotherapy and Oncology. 2023;184:109663.
  5. Stupp R, Taillibert S, Kanner A, et al. Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma: A Randomized Clinical Trial. JAMA. 2017;318(23):2306-2316.

Editor's note

Written by the Biruni Hospital medical editorial team. Reviewed by Prof. Dr. Mustafa Teoman YANMAZ, Medical Oncology.

Related Treatments

View All